These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 692381)

  • 41. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on carbohydrate and fatty acid metabolism in liver and muscle.
    Schudt C; Simon A
    Biochem Pharmacol; 1984 Nov; 33(21):3357-62. PubMed ID: 6437406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats.
    Collier GR; Traianedes K; Macaulay SL; O'Dea K
    Horm Metab Res; 1993 Jan; 25(1):9-12. PubMed ID: 8428713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic changes in fed rats caused by chronic administration of ethyl 2[5(4-chlorophenyl)pentyl]oxirane-2-carboxylate, a new hypoglycaemic compound.
    Koundakjian PP; Turnbull DM; Bone AJ; Rogers MP; Younan SI; Sherratt HS
    Biochem Pharmacol; 1984 Feb; 33(3):465-73. PubMed ID: 6231030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of the oral hypoglycemic agent pirogliride (McN-3495) on glycogen levels of normal and diabetic rats.
    Tutwiler GF; Fawthrop H
    Biochem Int; 1983 Jul; 7(1):55-62. PubMed ID: 6383388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of the glucose lowering effect of a carnitine palmitoyl transferase inhibitor in normal and diabetic rats.
    Martin C; Odeon M; Cohen R; Beylot M
    Metabolism; 1991 Apr; 40(4):420-7. PubMed ID: 2011084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes.
    Agius L; Pillay D; Alberti KG; Sherratt HS
    Biochem Pharmacol; 1985 Aug; 34(15):2651-4. PubMed ID: 2861821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of hepatic lipogenesis by 2-tetradecylglycidic acid.
    McCune SA; Nomura T; Harris RA
    Lipids; 1979 Oct; 14(10):880-2. PubMed ID: 502765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
    Rösen P; Reinauer H
    Acta Physiol Hung; 1988; 71(2):271-80. PubMed ID: 3389170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relation of ketosis to metabolic changes induced by acute medium-chain triglyceride feeding in rats.
    Yeh YY; Zee P
    J Nutr; 1976 Jan; 106(1):58-67. PubMed ID: 1245892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatty acid oxidation and glucose utilization interact to control food intake in rats.
    Friedman MI; Tordoff MG
    Am J Physiol; 1986 Nov; 251(5 Pt 2):R840-5. PubMed ID: 3777211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic inhibition of fatty acid oxidation: new model of diastolic dysfunction.
    Bressler R; Gay R; Copeland JG; Bahl JJ; Bedotto J; Goldman S
    Life Sci; 1989; 44(25):1897-906. PubMed ID: 2661944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incorporation of [U-14C]palmitate into rat brain: effect of an inhibitor of beta-oxidation.
    Chang MC; Grange E; Rabin O; Bell JM
    J Lipid Res; 1997 Feb; 38(2):295-300. PubMed ID: 9162749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of hyperglycemia and response to treatment with an inhibitor of fatty acid oxidation in a patient with insulin resistance due to antiinsulin receptor antibodies.
    Mandarino L; Tsalikian E; Bartold S; Marsh H; Carney A; Buerklin E; Tutwiler G; Haymond M; Handwerger B; Rizza R
    J Clin Endocrinol Metab; 1984 Oct; 59(4):658-64. PubMed ID: 6480801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decrease of fatty acid oxidation, ketogenesis and gluconeogenesis in isolated perfused rat liver by phenylalkyl oxirane carboxylate (B 807-27) due to inhibition of CPT I (EC 2.3.1.21).
    Wolf HP; Engel DW
    Eur J Biochem; 1985 Jan; 146(2):359-63. PubMed ID: 4038486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fatty acid oxidation affects food intake by altering hepatic energy status.
    Friedman MI; Harris RB; Ji H; Ramirez I; Tordoff MG
    Am J Physiol; 1999 Apr; 276(4):R1046-53. PubMed ID: 10198384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. JTT-608 controls blood glucose by enhancement of glucose-stimulated insulin secretion in normal and diabetes mellitus rats.
    Ohta T; Furukawa N; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Feb; 367(1):91-9. PubMed ID: 10082270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contribution of fat metabolism to 'glucoprivic' feeding produced by fourth ventricular 5-thio-D-glucose.
    Tordoff MG; Flynn FW; Grill HJ; Friedman MI
    Brain Res; 1988 Apr; 445(2):216-21. PubMed ID: 3370460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fatty acid oxidation modulates the eating response to the fructose analogue 2,5-anhydro-D-mannitol.
    Rawson NE; Ulrich PM; Friedman MI
    Am J Physiol; 1996 Jul; 271(1 Pt 2):R144-8. PubMed ID: 8760215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DECREASE IN THE CONCENTRATIONS OF KETONE BODIES AND FREE FATTY ACIDS IN RAT BLOOD IN RESPONSE TO A GLUCOSE LOAD: ITS POSSIBLE RELATION TO ENDOGENOUS INSULIN ACTIVITY.
    TANAYAMA S; UI M
    Endocrinology; 1965 May; 76():910-5. PubMed ID: 14290153
    [No Abstract]   [Full Text] [Related]  

  • 60. Hypoglycemic activity of 1-alpha-(3,4-dimethoxyphenethylaminomethyl) -2-hydroxybenzylalcohol 1/2 fumarate (TA-078) in the mouse, rat and dog.
    Iwai H; Inamasu M; Totsuka T; Shimazaki T; Morita T; Takeyama S
    Biochem Pharmacol; 1983 Mar; 32(5):849-55. PubMed ID: 6340689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.